Bladder Cancer | Tumor

Higher Tumor Classification and Grade for Nonmuscle-Invasive Bladder Cancer May Increase Recurrence and Progression Risk Up to Five Years

December 1st 2020, 7:30pm


Predicting risk for recurrence and progression in patients with nonmuscle-invasive bladder cancer may help when discussing management options with clinicians.

Immunotherapy Just After Chemo May Allow Some Patients with Bladder Cancer to Maintain Health Benefits

September 30th 2020, 9:00pm


Patients with advanced or metastatic bladder cancer, after responding to initial treatment with chemotherapy, may preserve their health improvements by starting immunotherapy immediately.

There is Help for Patients Dealing with Sexual Side Effects After Prostate, Bladder Cancer Treatment

September 30th 2020, 3:00pm


After treatment for bladder or prostate cancer, many survivors confront permanent sexual side effects. The good news is that treatments and psychological support are available.

FDA Approves Bavencio as Frontline Maintenance Therapy in Advanced Bladder Cancer

July 1st 2020, 3:39pm


The Food and Drug Administration approved Bavencio as a first-line maintenance therapy for patients with locally advanced or metastatic urothelial carcinoma.

Infigratinib Appears Active Across All Lines of Treatment in Patients With Advanced Bladder Cancer

June 16th 2020, 7:45pm


"These results suggest that infigratinib has activity in patients with advanced urothelial carcinoma, regardless of the line of treatment,” says lead study author Dr. Yung Lyou.

Cabometyx-Tecentriq Combination Produces 'Encouraging Clinical Activity' in Previously Treated Bladder Cancer

June 12th 2020, 5:00pm


At a median follow-up of 19.7 months, patients who received the combination achieved an objective response rate (the proportion of patients who had a complete or partial response to treatment) of 27%.

Bavencio Soon After Chemotherapy Improves Survival in Patients with Advanced Bladder Cancer

May 29th 2020, 5:00pm


The immunotherapy Bavencio improves survival when given as a maintenance treatment in patients whose advanced urothelial carcinoma did not progress on platinum-based chemotherapy.

Don't Ignore the Warning Signs of Cancer, Even During a Pandemic

May 19th 2020, 5:00pm


Even amid stay at home orders to mitigate the spread of the coronavirus, listen to your body and speak to your healthcare professionals when you are worried about a potential for cancer.

What Patients with Bladder Cancer Can Do When COVID-19 Impacts Their Care

May 16th 2020, 6:00pm


COVID-19 has drastically changed the landscape for patients with bladder cancer, but the new challenges are not insurmountable. CURE had the chance to interview the co-founder of the Bladder Cancer Advocacy Network to discuss these changes.

How One Organization is Honoring Bladder Cancer Awareness Month During the COVID-19 Pandemic

May 14th 2020, 10:00pm


Amid the COVID-19 pandemic, the Bladder Cancer Advocacy Network is honoring Bladder Cancer Awareness Month in a slightly different way from previous years.